In a prime example of the unique type of cross-collaboration that takes place at academic medical centers, Markey's stem cell lab is working together with the Kentucky Neuroscience Institute to bring an innovative stroke clinical trial to UK HealthCare.
New findings from University of Kentucky faculty published in Scientific Reports reveals a novel cell signaling interaction that may prevent a key step in lung cancer progression.
Kip Guy shares his research on neglected diseases, his goals as dean of the College of Pharmacy, and how pharmacy researchers are addressing the opioid epidemic.
The University of Kentucky Markey Cancer Center has joined the Oncology Research Information Exchange Network® (ORIEN), a personalized medicine consortium that allows its members to exchange data and push forward evidence-based cancer care to patients.
University of Kentucky Markey Cancer Center Researcher Jessica Blackburn has earned a prestigious National Institutes of Health's New Innovator Award, a grant totaling $1.5 million over five years to fund pediatric cancer research.
Many cancer survivors experience devastating cognitive impairment following chemotherapy. Researchers at UK are trying to identify strategies to relieve these symptoms.
In a new phase III trial report, recurrence and survival rates for women with stage I-II high-risk endometrial cancer were not superior following vaginal cuff brachytherapy & chemotherapy when compared with pelvic radiation therapy.
Angela Wei, an agricultural and medical biotechnology and mathematics senior from Lexington, was one of only five students across the country selected to participate in the 2017 Dartmouth MD/PhD Undergraduate Summer Fellowship Program.
